Kausik Ray MD FMedSci/LinkedIn
Nov 1, 2025, 05:15
Kausik Ray Celebrates MENA Launch of ACLY Inhibitor
Kausik Ray, Professor of Public Health at Imperial College London, Past President of European Atherosclerosis Society, posted on LinkedIn:
”One of the exciting things I have had the honoring of doing over the years are launch meetings. Bringing new therapies from the first PCSK9 MAbs, then to the first siRNA inclisiran and now the first ACLY inhibitor Bempedoic acid in the MENA region.
Good discussions about the CVD, lipids, guidelines and where new therapies sit in this this region at high risk for CVD.
The last 15 years of time spent on education, awareness, simplicity continue to help bring improvements in patient care.”
Stay informed with Hemostasis Today.
-
Feb 17, 2026, 16:34ISTH Names Five Global Recipients of 2026 Esteemed Career Awards
-
Feb 17, 2026, 16:16Flora Peyvandi: A Multicenter Initiative to Improve Guideline Adherence in Pediatric ITP
-
Feb 17, 2026, 16:14Hendrianus The: Intravenous Cangrelor in Hemodynamically Unstable Patients Undergoing PCI
-
Feb 17, 2026, 15:42Paul Wischmeyer: Nutrient Absorption in the GI Tract
-
Feb 17, 2026, 15:40Mahesan Subramaniam: Reversing Age-Related Decline in Blood Stem Cells
-
Feb 17, 2026, 15:38Wolfgang Miesbach: How a Single Mutation Can Flip Immunity into VITT
-
Feb 17, 2026, 15:34Jeff June: When Safety Warnings Outlive the Evidence – What Statins Teach Us About Stroke Prevention and Biology
-
Feb 17, 2026, 15:32Gabrielle Sarlon: Key Messages to Improve VTE Management in Women of Childbearing Age
-
Feb 17, 2026, 15:27Piezo1 Gain-of-Function Mutation Explains Thromboembolic Complications in Hereditary Xerocytosis – JTH